Imaging Analysis Suggests How Ketamine Treatment Might Have Helped Reduce Chronic PTSD Symptoms in Trial Subjects
A new study has analyzed detailed brain imaging data of individuals with chronic PTSD who were treated in a clinical trial with ketamine. Results suggest that improvements in PTSD symptoms that were observed in the trial were related to specific ketamine-induced changes in connectivity between several brain regions.
The new results offer clues about how ketamine may alter brain function in PTSD and may also have therapeutic implications.